GT Biopharma

GT Biopharma, Inc. is a clinical-stage biopharmaceutical company based in Westlake Village, California, dedicated to the development and commercialization of innovative immuno-oncology products. The company focuses on creating therapeutic candidates for cancer treatment, including GTB-1550, a bispecific fusion protein-drug conjugate in Phase 2 clinical trials, and GTB-3550, a tri-specific fusion protein currently in Phase 1 trials. Additionally, GT Biopharma is advancing GTB-C3550, a next-generation candidate, and GTB-1615, aimed at treating solid tumors. The company's portfolio also includes products targeting central nervous system disorders, such as GTP-004 for myasthenia gravis and PainBrake for chronic neuropathic pain. GT Biopharma has established partnerships for the development of novel therapies, including a collaboration with Altor BioScience for a TriKE fusion protein and a partnership with Cytovance Biologics for a TriKE therapeutic related to coronavirus. Founded in 1965, GT Biopharma continues to pursue advancements in several therapeutic areas, primarily focusing on oncology.

Michael Breen

Executive Chairman, Board of Directors, Interim CEO

Ronan Lambe Ph.D

Co-Founder and Board Member

2 past transactions

BioCheck

Acquisition in 2005
BioCheck operates a 15,000 square-foot FDA-certified cGMP device-manufacturing facility in Foster City, California. The company specializes in the development, manufacture, and distribution of enzyme immunoassay test kits and research reagents for the biomedical, pharmaceutical, and scientific research markets. BioCheck offers a diverse range of immunoassay kits designed to detect various classifications, including cardiac markers, tumor markers, infectious diseases, thyroid function, steroids, and fertility hormones. Additionally, the company is advancing the field of diagnostics through the development of ultra-sensitive assays using Simoa technology and diagnostic test kits utilizing an MS-Fast chemiluminescent platform, enabling convenient, instant, and accurate disease diagnosis.

Innovative Medical Systems

Acquisition in 1998
Innovative Medical Systems, Inc. specializes in the marketing, installation, and servicing of medical information systems and patient data technologies for hospitals, long-term care facilities, and physician practices across the United States. Established in 1988 and headquartered in Grand Rapids, Michigan, the company provides a range of products, including obstetrical systems, radio frequency identification solutions, mobile computer carts, and vital signs monitoring systems. As an experienced integrator of complex hospital hardware and software, Innovative Medical Systems focuses on custom-designed solutions that enhance workflow and reduce costs by effectively integrating various components. Their approach emphasizes collaboration and comprehensive support, ensuring that healthcare facilities can navigate the complexities of modern medical technology. The company operates as a subsidiary of Convergint Technologies LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.